共 50 条
- [31] The Protective Effects of Bevacizumab in Bleomycin-Induced Experimental Scleroderma ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 25 (02): : 249 - 253
- [34] Increased expression of p53 and p21 (Waf1/Cip1) in the lesional skin of bleomycin-induced scleroderma Archives of Dermatological Research, 2005, 296 : 509 - 513
- [39] CD109 Overexpression Ameliorates Skin Fibrosis in a Mouse Model of Bleomycin-Induced Scleroderma ARTHRITIS AND RHEUMATISM, 2013, 65 (05): : 1378 - 1383
- [40] The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis? Archives of Dermatological Research, 2006, 297 : 333 - 344